Calamos Advisors
IDXX icon

Calamos Advisors’s Idexx Laboratories IDXX Stock Holding History

Calamos Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,400
Closed -$366K – 741
2019
Q4 		$366K Hold
1,400
– – ﹤0.01% 735
2019
Q3 		$381K Buy
+1,400
New +$390K ﹤0.01% 714
2019
Q2 		– Sell
-19,881
Closed -$4.45M – 759
2019
Q1 		$4.45M Buy
19,881
+200
+1% +$41.3K 0.03% 483
2018
Q4 		$3.66M Buy
19,681
+2,947
+18% +$604K 0.02% 498
2018
Q3 		$4.18M Sell
16,734
-2,934
-15% -$712K 0.02% 505
2018
Q2 		$4.29M Sell
19,668
-4,579
-19% -$944K 0.03% 474
2018
Q1 		$4.64M Buy
24,247
+1,148
+5% +$212K 0.03% 446
2017
Q4 		$3.61M Sell
23,099
-541
-2% -$85.2K 0.02% 459
2017
Q3 		$3.68M Buy
23,640
+877
+4% +$139K 0.03% 426
2017
Q2 		$3.67M Buy
22,763
+615
+3% +$99.9K 0.03% 439
2017
Q1 		$3.42M Buy
+22,148
New +$3.05M 0.03% 413

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Calamos Advisors's IDXX Position: Q1 2020 in Review

Calamos Advisors sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 1,400 shares — an estimated $366K sold.

Calamos Advisors first reported a position in IDXX in Q1 2017 and held it in 11 quarters. The position peaked at $4.64M in Q1 2018. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

  • Calamos Advisors reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
  • Calamos Advisors sold 1,400 Idexx Laboratories shares in Q1 2020, an estimated $366K.
  • Calamos Advisors first reported a position in Idexx Laboratories in Q1 2017 and held it in 11 quarters.
  • Calamos Advisors's Idexx Laboratories position peaked at $4.64M in Q1 2018.
  • 748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Calamos Advisors's 13F filing for Q1 2020, filed 28 Apr 2020.